Balloon Dilation Of The Cartilaginous Portion Of The Eustachian Tube: Initial Safety And Feasibility Analysis In A Cadaver Model

Abstract

Background: Balloon catheter dilation of diseased sinus ostia has recently demonstrated efficacy ☆ Disclaimer: Th interest with Acclaren ☆☆ Presented as Phoenix, AZ, May 28 ⁎ Corresponding Hospital, 300 Longwo 617 355 3794. E-mail address: d 0196-0709/$ – see fro doi:10.1016/j.amjoto.2 and safety in the treatment of chronic sinus disease with 2 years of follow-up. Similar to sinus surgery, initial studies of partial resection of inflamed mucosa from within the cartilaginous eustachian tube (ET) have demonstrated efficacy and safety in the treatment of medically refractory otitis media with effusion. Therefore, balloon dilation of the cartilaginous ET was investigated as a possible treatment modality for otitis media. Methods: A protocol for sinus balloon catheter dilation was evaluated in each of the cartilaginous ETs in 8 fresh human cadaver heads. Computed tomographic scans and detailed endoscopic inspections with video or photographic documentation were performed preand posttreatment, and gross anatomical dissections were done to analyze the effects of treatment and to look for evidence of undesired injury. Results: Catheters successfully dilated all cartilaginous ETs without any significant injuries. There were no bony or cartilaginous fractures, and 3 specimens showed minor mucosal tears in the anterolateral or inferior walls. Volumetric measurements of the cartilaginous ET lumens showed a change from an average of 0.16 to 0.49 cm (SD, 0.12), representing an average increase of 357% (range, 20–965%). Conclusions: Balloon catheter dilation of the nasopharyngeal orifice of the ET was shown to be feasible and without evidence of untoward injury. A significant increase in volume of the cartilaginous ET was achieved. A clinical study is now indicated to determine whether balloon dilation will demonstrate lasting benefits and safety in the treatment of otitis media. © 2011 Elsevier Inc. All rights reserved.